Table 5.

Predictors of non HDL-C goal attainment

	Initial model		Final model
	OR (95% CIs)	P-value	OR (95% CIs)	P-value
Male gender	1.04 (0.50-2.17)	0.9
Age	1.01 (0.98-1.05)	0.4
DM	0.78 (0.33-1.87)	0.6
Smoking	0.65 (0.31-1.36)	0.2
CAD	1.61 (0.75-3.45)	0.2	1.80 (0.95-3.42)	0.07
PAD	1.71 (0.62-4.66)	0.3
Cerebrovascular disease	0.64 (0.17-2.35)	0.5
Baseline LDL-C (mg/dl)	0.98 (0.97-0.99)	0.001	0.98 (0.97-0.99)	<0.001
Combined therapy with statin and ezetimibe	1.92 (0.81-4.56)	0.1
Very high potency LDL-C lowering regimen	1.06 (0.36-3.10)	0.9
Fenofibrate	1.05 (0.34-3.42)	0.9
n3 fatty acids

DM = diabetes mellitus, CAD = coronary artery disease, PAD = peripheral arterial disease, LDL-C = low density lipoprotein-cholesterol.